Social networks
3,156 22,923Activities
Technologies
Entity types
Location
395 Winchester Ave, New Haven, CT 06511, USA
New Haven
United States of America
Employees
Scale: 201-500
Estimated: 444
Engaged corporates
4Added in Motherbase
1 year, 7 months agoLeading the way in targeted protein degradation therapeutics
Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Arvinas is currently progressing multiple investigational drugs through clinical development programs, including vepdegestrant, targeting estrogen receptor for patients with locally advanced or metastatic ER+/HER2- breast cancer; ARV-102, targeting LRRK2 for neurodegenerative disorders; and ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin Lymphoma.
Based in the biotech hub of New Haven, CT, Arvinas is driven by an industry-leading team dedicated to improving the lives of people living with serious diseases. For more information, visit www.arvinas.com.
Community Guidelines: http://bit.ly/ArvinasCG
Arvinas is a clinical-stage biotechnology company leading the way in targeted protein degradation therapeutics.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
J.P. Morgan Bank | J.P. Morgan Bank | Other 5 Jan 2024 | | |
Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Other 5 Nov 2024 | | |
Amgen Biotechnology, Biotechnology Research | Amgen Biotechnology, Biotechnology Research | Other 5 Mar 2021 | | |
Bayer Pharmaceutical, Chemistry, Chemical Manufacturing | Bayer Pharmaceutical, Chemistry, Chemical Manufacturing | Other 8 Jan 2020 | |